Frontiers in Oncology (Nov 2021)
Corrigendum: CircHIPK3 Promotes Metastasis of Gastric Cancer via miR-653-5p/miR-338-3p-NRP1 Axis Under a Long-Term Hypoxic Microenvironment
- Yue Jin,
- Yue Jin,
- Yue Jin,
- Yue Jin,
- Xiaofang Che,
- Xiaofang Che,
- Xiaofang Che,
- Xiaofang Che,
- Xiujuan Qu,
- Xiujuan Qu,
- Xiujuan Qu,
- Xiujuan Qu,
- Xin Li,
- Wenqing Lu,
- Wenqing Lu,
- Wenqing Lu,
- Wenqing Lu,
- Jie Wu,
- Jie Wu,
- Jie Wu,
- Jie Wu,
- Yizhe Wang,
- Yizhe Wang,
- Yizhe Wang,
- Yizhe Wang,
- Kezuo Hou,
- Kezuo Hou,
- Kezuo Hou,
- Kezuo Hou,
- Ce Li,
- Ce Li,
- Ce Li,
- Ce Li,
- Xiaojie Zhang,
- Xiaojie Zhang,
- Xiaojie Zhang,
- Xiaojie Zhang,
- Jianping Zhou,
- Yunpeng Liu,
- Yunpeng Liu,
- Yunpeng Liu,
- Yunpeng Liu
Affiliations
- Yue Jin
- Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China
- Yue Jin
- Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China
- Yue Jin
- Liaoning Province Clinical Research Center for Cancer, Shenyang, China
- Yue Jin
- Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, Shenyang, China
- Xiaofang Che
- Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China
- Xiaofang Che
- Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China
- Xiaofang Che
- Liaoning Province Clinical Research Center for Cancer, Shenyang, China
- Xiaofang Che
- Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, Shenyang, China
- Xiujuan Qu
- Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China
- Xiujuan Qu
- Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China
- Xiujuan Qu
- Liaoning Province Clinical Research Center for Cancer, Shenyang, China
- Xiujuan Qu
- Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, Shenyang, China
- Xin Li
- Department of Gastrointestinal Surgery, The First Hospital of China Medical University, Shenyang, China
- Wenqing Lu
- Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China
- Wenqing Lu
- Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China
- Wenqing Lu
- Liaoning Province Clinical Research Center for Cancer, Shenyang, China
- Wenqing Lu
- Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, Shenyang, China
- Jie Wu
- Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China
- Jie Wu
- Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China
- Jie Wu
- Liaoning Province Clinical Research Center for Cancer, Shenyang, China
- Jie Wu
- Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, Shenyang, China
- Yizhe Wang
- Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China
- Yizhe Wang
- Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China
- Yizhe Wang
- Liaoning Province Clinical Research Center for Cancer, Shenyang, China
- Yizhe Wang
- Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, Shenyang, China
- Kezuo Hou
- Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China
- Kezuo Hou
- Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China
- Kezuo Hou
- Liaoning Province Clinical Research Center for Cancer, Shenyang, China
- Kezuo Hou
- Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, Shenyang, China
- Ce Li
- Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China
- Ce Li
- Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China
- Ce Li
- Liaoning Province Clinical Research Center for Cancer, Shenyang, China
- Ce Li
- Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, Shenyang, China
- Xiaojie Zhang
- Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China
- Xiaojie Zhang
- Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China
- Xiaojie Zhang
- Liaoning Province Clinical Research Center for Cancer, Shenyang, China
- Xiaojie Zhang
- Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, Shenyang, China
- Jianping Zhou
- Department of Gastrointestinal Surgery, The First Hospital of China Medical University, Shenyang, China
- Yunpeng Liu
- Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China
- Yunpeng Liu
- Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China
- Yunpeng Liu
- Liaoning Province Clinical Research Center for Cancer, Shenyang, China
- Yunpeng Liu
- Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, Shenyang, China
- DOI
- https://doi.org/10.3389/fonc.2021.783320
- Journal volume & issue
-
Vol. 11
Abstract
No abstracts available.Keywords
